MedNexus
2015年 · 第95卷第35期
MedNexus
- 全部
- 临床研究
- 基础研究
- 病例报告
- 综述
A 27-year-old male, right-handed, was transferred from another hospital to the Department of Neurosurgery, General Hospital of Tianjin Medical University with "weakness of both lower limbs for 1 week". One week before admission, the patient showed a progressive decrease in strength of both lower limbs and limited movement. By the time of admission, he could no longer walk, had no urinary incontinence or retention, and took a flat car to enter the ward. Previous history of gout for 4 years, denied history of trauma and tumor. Physical examination at admission: obese, weight about 110 kg, body mass index (BMI) 32.14, clear, no scoliosis deformity of the spine, multiple subcutaneous nodules palpable on the back of both feet, local skin slightly red, hard at touch, no obvious tenderness, muscle strength of both upper limbs grade V, muscle strength of both lower limbs grade III–Grade, superficial hypoesthesia below the umbilical level, bilateral Pap sign (+). CT of both feet showed several round-like nodules in the subcutaneous soft tissues of the proximal parts of the 1st to 5th metatarsal bones of both feet, considering gout nodules; CT of the thoracic spine showed that T9~10 intervertebral discs occupied space inside and outside the spinal canal at the level, and extended outward along the intervertebral foramen on both sides, with the left side as the focus (
A 66-year-old woman was admitted for "intermittent abdominal pain with fatigue for half a year". The patient had abdominal pain intermittently without obvious trigger six months ago, which was slightly relieved after eating, accompanied by fatigue and dyspnea after activity. After admission, physical examination showed upper abdominal palpation discomfort, and no pigmentation was seen on the skin and mucosa of the whole body. Laboratory tests: Moderate anemia; Hypoalbuminemia; Positive fecal occult blood test. Gastroscopy: scattered dark spots can be seen in the whole gastric mucosa, with 2 biopsies; Dark spots were seen in the retrobulbar mucosa of the duodenum, and one piece was biopsied. Colonoscopy: Multiple nevus-like black nodules, 0.4 to 0.5 cm in size, were seen in the colon 1 to 7 cm away from the anus, and one piece was biopsied. Abdominal ultrasound: Multiple homogeneous anechoic nodules scattered under the xiphoid process, between the muscular layer of the right abdomen and the left upper abdomen and the peritoneum (
A 24-year-old male was seen with an occipital mass for 1 year and dizziness for 5 days. The patient had no enlargement of the mass and no pain for 1 year. 5 days ago, sudden dizziness and blurred vision came to the clinic. Physical examination showed that the occipital mass was 5 cm ×3 cm in size, tough in texture, no movement, no tenderness, and no redness and swelling of the scalp. There were no abnormalities in laboratory blood routine and tumor markers such as carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP) and CA125. CT of the brain showed a bone destruction area in the occipital scale, with regular edges and no sclerosis, and the size was 3.6 cm ×4.5 cm; Local soft tissue mass was formed, and the mass was isolow density. The CT value in the low density area was about 19 HU, and the CT value in the isolow density area was about 40 HU (
A 52-year-old male was admitted to the Department of Encephalology, Affiliated Hospital of Tianjin Academy of Traditional Chinese Medicine on December 25, 2014 due to "disadvantageous left limb movement with disadvantageous language for 9 days". When admitted to the hospital, he saw clear spirit, poor spirit, sleep, agitation, poor movement of the left limb, conscious numbness of the right upper limb and left lower limb, poor speech, occasional choking and cough, occasional sputum, poor appetite, poor sleep, stools for 2 days, and urine adjustment. A previous history of cerebral infarction was 1 month, and a history of diabetes was 3 years. Neurological examination: left metacarpomandibular reflex (+), right Pap sign (+), specialist examination: left upper limb muscle strength grade III, left lower limb muscle strength grade I. Auxiliary examination: Head CT (December 25, 2014) showed: (1) multiple cerebral infarctions and malacia in pons, bilateral basal ganglia region-thalamus, left frontal lobe and bilateral hemioval center; (2) sparse white matter; (3) Brain atrophy. The diagnosis was "acute stage of cerebral infarction". After admission, he was treated with integrated traditional Chinese and western medicine to improve cell metabolism and circulation. Because the patient's right limb was agitated from time to time, he visited Anding Hospital many times and asked for consultation in the psychosomatic department of our hospital. He was treated with alprazolam, zopiclone, trihexyphenidyl hydrochloride, haloperidol and olanzapine for sedation, sleep aid, anticholinergic and antipsychotic treatment. However, the agitation of the limbs could not be alleviated, the movements were violent, and even the property was damaged and the limbs were bruised, so he asked for consultation on January 1, 2015. During sleep, the patient was turbid after waking up, accompanied by disorientation and restlessness, and woke up after about 5 minutes. Contact is acceptable, autonomy is incomplete, speech is unfavorable, right limb has no purpose movement, and cannot be controlled. Ask family members, the patient had been depressed and uncomfortable due to family conflicts, and then had cerebral infarction. The possibility of delirium cannot be ruled out. The prescription is as follows: oral, alprazolam tablets 0.4 mg once in the morning and afternoon, 0.8 mg before bed, sertraline hydrochloride capsules 25 mg with breakfast, increased to 50 mg with breakfast after 4 days, and trazodone hydrochloride 50 mg before bed to achieve sedation and antidepressant treatment. On January 8th, the overall symptoms of the patient were still stable, his mood improved slightly, and he could sleep. In the evening, he had transient visual hallucinations, language disorder and agitation, and it was still necessary to exclude visual hallucinations and falsehoods as delirium. The prescription is as follows: alprazolam tablets 0.2 mg once in the morning and afternoon, 0.6 mg before bedtime, sertraline hydrochloride capsules 75 mg with breakfast, trazodone hydrochloride 75 mg before bedtime, zopiclone 7.5 mg before bedtime, orally; When agitated, add 2 ml of diazepam to push slowly to achieve sedation, antidepressant and sleep-helping effects.
The blood vessel was once considered a "steel" tube. The phenomenon of vascular lumen dilatation with the increase of plaque volume in patients with atherosclerosis caused scholars to study the "vascular wall changes" in the process of disease, and then put forward the concept of "vascular remodeling". Until Gibbons et al.[
Negative symptoms play an important role in the evolution of the course of schizophrenia, easily accompanied by a slow loss of interest and ability during the development of the disease, ultimately leading to severe functional disability. Therefore, it is important to treat negative symptoms early. Because the biological mechanism of negative symptoms is complex, it is difficult to explain with a single biological hypothesis or genetic factors, and there is a lack of effective targeted therapy. At present, there is no satisfactory effective treatment for negative symptoms. Recent research suggests that negative symptoms of schizophrenia may be related to abnormal activation of glutamatergic system and microglia[
Both lopinavir (LPV) and ritonavir (RTV) belong to human immunodeficiency virus (HIV) protease inhibitors, and their compound preparation, lopinavir combined with low-dose ritonavir tablets (LPV/r), is a protease inhibitor drug widely used in the clinical treatment of HIV-1 infection internationally. It is currently used as one of the second-line antiretroviral drugs of choice in China. By interfering with HIV protease, the structural and functional proteins of the virus core cannot be expressed correctly, resulting in the formation of immature and non-infectious virus particles, thus achieving the effect of inhibiting HIV replication. Co-administration of LPV with low-dose RTV can significantly enhance its pharmacokinetic profile and enhance its anti-HIV-1 activity[
本期目次

